<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Peri-RSI hypotension: Common causes and interventions</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Peri-RSI hypotension: Common causes and interventions</h1>
<div class="graphic"><div class="figure"><div class="ttl">Peri-RSI hypotension: Common causes and interventions</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Common causes</td> <td class="subtitle1">Important clinical findings</td> <td class="subtitle1">Interventions</td> <td class="subtitle1">Prevention/preparation</td> </tr> <tr class="divider_bottom"> <td>High intrathoracic pressure <ul class="decimal_heading"> <li>Poor BMV ventilation technique </li> <li>Improper mechanical ventilation settings </li> </ul> </td> <td> <ul> <li>Normal or elevated airway pressures </li> <li>Abnormal breath sounds (eg, wheezing, diminished) </li> </ul> </td> <td> <ul> <li>Slow ventilation rate (≤8 bpm) </li> <li>Reduce ventilation force (for BMV) </li> <li>Increase expiration time </li> <li>IV bolus isotonic fluid </li> </ul> </td> <td> <ul> <li>Avoid overly rapid or forceful ventilation </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Induction agent effects</td> <td> <ul> <li>Occurs within minutes of drug administration </li> <li>Transient effect </li> <li>Resolves with IVF bolus and time </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid </li> <li>Norepinephrine infusion </li> <li>Exclude other serious causes </li> <li>Monitor for resolution </li> </ul> </td> <td> <ul> <li>Prepare norepinephrine infusion prior to giving induction agent to patient with hypotension or signs of hemodynamic instability </li> <li>Consider push-dose pressor* </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Significant prior or ongoing fluid loss</td> <td> <ul> <li>Signs of shock </li> <li>SI &gt;0.8 </li> <li>POCUS shows decreased IVC diameter and hyperdynamic heart </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid; repeat as needed </li> </ul> </td> <td> <ul> <li>In hypotensive or high-risk patients, give IVF bolus prior to administering RSI medications </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Significant prior or ongoing hemorrhage</td> <td> <ul> <li>Blood loss </li> <li>Signs of shock </li> <li>Pallor </li> </ul> </td> <td> <ul> <li>Blood transfusion </li> <li>Hemorrhage control/surgical consultation </li> </ul> </td> <td> <ul> <li>In patients with hemorrhagic shock or at risk for hemodynamic instability, initiate blood transfusion prior to administering RSI medications </li> </ul> </td> </tr> <tr> <td colspan="4">Obstructive shock</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Pulmonary embolism </li> </ul> </td> <td> <ul> <li>Possible hypoxemia </li> <li>Lower extremity swelling </li> <li>Dilated RV on POCUS or bedside echo </li> </ul> </td> <td> <ul> <li>Norepinephrine infusion </li> <li>iNO or epoprostenol (reduce PVR) </li> </ul> </td> <td class="divider_bottom" rowspan="2"> <ul> <li>Give norepinephrine early as needed </li> <li>Consider push-dose pressor* </li> <li>For shock caused by PE, avoid intubation if possible; use BPAP or iNO to improve oxygenation/ventilation </li> <li>Ketamine is preferred induction agent for patients in non-cardiogenic shock; avoid propofol </li> <li>Reduce dose of induction agent<sup>¶</sup> </li> <li>In hypotensive or high-risk patients with tamponade, give IVF bolus prior to administering RSI medications </li> </ul> </td> </tr> <tr class="divider_bottom"> <td> <ul class="decimal_heading"> <li>Cardiac tamponade </li> </ul> </td> <td> <ul> <li>Distended neck veins, if patient not volume depleted </li> <li>POCUS shows pericardial effusion and compression of RA and RV </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid </li> <li>Pericardiocentesis </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Cardiogenic shock</td> <td> <ul> <li>Crackles, distended neck veins, cool extremities </li> <li>ECG may show ischemia </li> <li>POCUS shows poor contractility, B lines </li> <li>Chest radiograph may show signs of ADHF </li> </ul> </td> <td> <ul> <li>Minimize PEEP </li> <li>Vasopressor (norepinephrine) and inotrope (dobutamine) infusions </li> <li>Interventional cardiology consult (catheterization; IABP; LVAD) </li> </ul> </td> <td> <ul> <li>BPAP as indicated before RSI </li> <li>Etomidate is preferred induction agent for patients in cardiogenic shock; avoid propofol </li> <li>Prepare norepinephrine infusion prior to giving induction agent </li> <li>Consider push-dose pressor* </li> </ul> </td> </tr> <tr> <td colspan="4">Distributive shock</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Sepsis </li> </ul> </td> <td> <ul> <li>Fever, hypotension, tachycardia, focal signs of infection </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid; repeat as needed </li> <li>Norepinephrine infusion for sepsis </li> </ul> </td> <td class="divider_bottom" rowspan="2"> <ul> <li>In hypotensive or high-risk patients, give IVF bolus prior to administering RSI medications </li> <li>Ketamine is preferred induction agent for patients in non-cardiogenic shock; avoid propofol </li> <li>Give norepinephrine for sepsis early as needed </li> <li>Reduce dose of induction agent<sup>¶</sup> </li> <li>Consider push-dose pressor* </li> </ul> </td> </tr> <tr class="divider_bottom"> <td> <ul class="decimal_heading"> <li>Anaphylaxis </li> </ul> </td> <td> <ul> <li>Skin and mucosal signs (hives, flushing, edema) </li> <li>Respiratory signs (wheeze, cough, congestion) </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid; repeat as needed </li> <li>Epinephrine for anaphylaxis </li> </ul> </td> </tr> <tr> <td>Older adult patient with poor CV reserve</td> <td> <ul> <li>Frail appearing </li> <li>ECG may show ischemia </li> <li>History of CAD or reduced EF </li> </ul> </td> <td> <ul> <li>IV bolus isotonic fluid </li> <li>Norepinehrine infusion </li> </ul> </td> <td> <ul> <li>Prepare norepinephrine infusion prior to giving induction agent </li> <li>Reduce dose of induction agent<sup>¶</sup> </li> <li>Consider push-dose pressor* </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">RSI: rapid sequence intubation; BMV: bag-mask ventilation; bpm: beats per minute; IV: intravenous; IVF: intravenous fluid; SI: shock index; POCUS: point-of-care ultrasound; IVC: inferior vena cava; RV: right ventricle; iNO: inhaled nitric oxide; PVR: pulmonary vascular resistance; PE: pulmonary embolism; BPAP: bilevel positive airway pressure; RA: right atrium; ECG: electrocardiogram; ADHF: acute decompensated heart failure; PEEP: peak end-expiratory pressure; IABP: intra-aortic balloon pump; LVAD: left-ventricular assist device; CV: cardiovascular; CAD: coronary artery disease; EF: ejection fraction; SBP: systolic blood pressure.<br/>* The use of a push-dose pressor is based on clinical judgement. It is most appropriate for patients with overt shock (eg, SBP &lt;90 mmHg, SI &gt;1) but may be useful in any hemodynamically unstable patient being intubated. Options include phenylephrine 100 microgram (50 to 200 microgram) IV or epinephrine 10 microgram (5 to 20 microgram) IV, depending upon whether vasoconstriction alone or vasoconstriction and inotropic support is desired. Appropriate measures to improve hemodynamics as much as possible should be taken prior to intubation and push-dose pressor use.<br/>¶ Reductions in the dose of the induction agent depend upon clinical circumstance. In general, the authors reduce the ketamine dose by 50% when a reduction is needed. Reductions in the etomidate dose are generally not necessary.</div><div id="graphicVersion">Graphic 120804 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
